КУРКУМИН — ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ОРГАНОВ ПИЩЕВАРЕНИЯ
Аннотация
Воспаление лежит в основе развития большинства заболеваний. В последние годы все больше внимания уделяется куркумину — активному полифенолу, содержащемуся в корне куркумы, который обладает многочисленными благотворными воздействиями на организм человека, включая противовоспалительное, антиканцерогенное и антиоксидантное свойства. Куркумин воздействует на несколько клеточных путей и оказывает влияние на состав микробиоты кишечника. В данном обзоре обобщены современные сведения о перспективах использования куркумина в терапии заболеваний пищеварительной системы.
Литература
Perrone D., Ardito F., Giannatempo G. et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp. Med. 2015;10:1615–1623. DOI: 10.3892/etm.2015.2749.
European Food Safety Authority Panel on Food Additives and Nutrient Sources added to Food. Scientific Opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA J. 2010;8:1679.
Kharat M., Du Z., Zhang G., McClements D.J. Physical and chemical stability of curcumin in aqueous solutions and emulsions: impact of pH, temperature and molecular environment. J. Agric. Food Chem. 2017;65:1525–1532. DOI: 10.1021/acs.jafc.6b04815.
Scazzocchio B., Minghetti L., D’Archivio M. Interaction between gut microbiota and curcumin: A new key of understanding for the health effects of curcumin. Nutrients. 2020;12:2499. DOI: 10.3390/nu12092499.
Peterson C.T., Vaughn A.R., Sharma V. et al. Effects of turmeric and curcumin dietary supplementation on human gut microbiota: A double-blind, randomized, placebo-controlled pilot study. J. Evid. Based Integr. Med. 2018;23:2515690X18790725. DOI: 10.1177/2515690X18790725.
Tabanelli R., Brogi S., Calderone V. Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics. 2021;13:1715. DOI: 10.3390/pharmaceutics13101715.
Sasaki H., Sunagawa Y., Takahashi K. et al. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 2011;34:660–665.
Schiborr C., Kocher A., Behnam D. et al. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 2014;58:516–527.
Olcum M., Tastan B., Ercan I. et al. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: a review. Phytomedicine. 2020;75:153238. DOI: 10.1016/j.phymed.2020.153238.
Ashrafizadeh M., Rafiei H., Mohammadinejad R. et al. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: a review. Phytother Res. 2020;34(8):1745–1760. DOI: 10.1002/ptr.6642.
Wang Y., Tang Q., Duan P., Yang L. Curcumin
as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol.
Immunotoxicol. 2018;40:476–482. DOI: 10.1080/ 08923973.2018.1469145.
Rahimi K., Ahmadi A., Hassanzadeh K. et al. Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states. Autoimmun Rev. 2019;18(7):738–748. DOI: 10.1016/j.autrev.2019.05.012.
Yousefian M., Shakour N., Hosseinzadeh H. et al. The natural phenolic compounds as modulators of NADPH oxidases in hypertension. Phytomedicine. 2019;55:200–213. DOI: 10.1016/j.phymed.2018.08.002.
Kato M., Nishikawa S., Ikehata A. et al. Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol. Nutr. Food Res. 2016;61:3. DOI: 10.1002/mnfr.201600471.
Ng Q.X., Soh A.Y.S., Loke W. et al. A Meta-analysis of the clinical use of curcumin for irritable bowel syndrome (IBS). J. Clin. Med. 2018;7:298. DOI: 10.3390/jcm7100298.
Jabczyk M., Nowak J., Hudzik B., Zubelewicz-Szkodzi´nska B. Curcumin and its potential impact on microbiota. Nutrients. 2021;13:2004. DOI: 10.3390/nu13062004.
Hassaninasab A., Hashimoto Y., Tomita-Yokotani K., Kobayashi M. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc. Natl. Acad. Sci. USA. 2011;108:6615–6620. DOI: 10.1073/pnas.1016217108.
Jazayeri S.D. Survival of Bifidobacteria and other selected intestinal bacteria in TPY medium supplemented with curcumin as assessed in vitro. Int. J. Probiotics Prebiorics. 2009;4:15–22.
Shen L., Liu L., Hong-Fang J. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr. Res. 2017;61:1361780. DOI: 10.1080/16546628.2017.1361780.
Feng W., Wang H., Zhang P. et al. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochim. Biophys. Acta. 2017;1861:1801–1812. DOI: 10.1016/j.bbagen.2017.03.017.
Lopresti A.L., Smith S.J., Rea A., Michel S. Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: A randomized, double-blind, placebo-controlled study. BMC Complementary Med. Ther. 2021; 21: 4. DOI: 10.1186/s12906-021-03220-6.
McFadden R.M., Larmonier C.B., Shehab K.W. et al. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm. Bowel Dis. 2015;21:2483–2494. DOI: 10.1097/MIB.0000000000000522.
Ohno M., Nishida A., Sugitani Y. et al. Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS ONE. 2017;12:e0185999. DOI: 10.1371/journal.pone.0185999.
Хавкин А.И., Налетов А.В., Шумилов П.В., Ситкин С.И., Марченко Н.А. Диетические аспекты лечения воспалительных заболеваний кишечника. Вопросы детской диетологии. 2024;22(1):51–62. DOI: 10.20953/1727-5784-2024-1-51-62.
Хавкин А.И., Налетов А.В., Марченко Н.А. Кишечная микробиота и микроРНК при воспалительных заболеваниях кишечника. Вопросы диетологии. 2023;13(4):55–63. DOI: 10.20953/2224-5448-2023-4-55-63.
Chen Y.-M., Chiu W.-C., Chiu Y.-S. et al. Supplementation of nano-bubble curcumin extract improves gut microbiota composition and exercise performance in mice. Food Funct. 2020;11:3574–3584. DOI: 10.1039/C9FO02487E.
Налетов А.В., Пушкарук В.В. Микробиотический кишечный дисбаланс у детей с неалкогольной жировой болезнью печени. Мать и дитя в Кузбассе. 2023;4(95):64–68.
Хавкин А.И., Новикова В.П., Маталыгина О.А., Завьялова А.Н. Аллергия и ожирение: выявление общих звеньев патогенеза как основа стратегии адекватной терапии. Вопросы практической педиатрии. 2022;17(4):59–66. DOI: 10.20953/1817-7646-2022-4-59-66.
Zhang Z., Chen Y., Xiang L. et al. Effect of curcumin on the diversity of gut microbiota in ovearectomized rats. Nutrients. 2017;9:1146. DOI: 10.3390/nu9101146.
Chandan S., Mohan B.P., Chandan O.C. et al. Curcumin use in ulcerative colitis: Is it ready for prime time? A systematic review and meta-analysis of clinical trials. Ann. Gastroenterol. 2020;33:53–58. DOI: 10.20524/aog.2019.0439.
Zheng T., Wang X., Chen Z. et al. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 2020;35:722–729. DOI: 10.1111/jgh.14911.
Coelho M.R., Romi M.D., Ferreira D.M.T.P. et al. The use of curcumin as a complementary therapy in ulcerative colitis: A systematic review of randomized controlled clinical trials. Nutrients 2020;12:2296. DOI: 10.3390/nu12082296.
Goulart R.A., Barbalho S.M., Rubira C.J. et al. Curcumin therapy for ulcerative colitis remission: Systematic review and meta-analysis. Expert Rev. Gastroenterol. Hepatol. 2020;14:1171–1179. DOI: 10.1080/17474124.2020.1808460.
Yin J., Wei L., Wang N. et al. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis. J. Ethnopharmacol. 2022;289:115041. DOI: 10.1016/j.jep.2022.115041.
